Position in ALKS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$8,331
+$7,200 QoQ
Shares Held
159
+396.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#360
of 421 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CVA Family Office, LLC holds $193,049 across 16 Drug Manufacturers - Specialty & Generic names. ALKS ranks #6 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
4,734 | $75,175 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
67 | $36,302 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
103 | $17,359 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
680 | $16,734 | |
| 5 | ZTS |
Zoetis Inc.
|
214 | $15,378 | |
| 6 | ALKS |
Alkermes plc.
This page
|
159 | $8,331 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
65 | $7,211 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
260 | $4,500 |
All Filings in ALKS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,331 | 159 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,131 | 32 | Shares | Sole | 2026-04-29 | |
| No filing history on record for this holder in this stock. | ||||||